A study comparing markers of nerve cell damage with cholesterol-related markers in MS patients revealed that lower serum levels of ApoA-II and ApoA-I were associated with increased nerve cell damage, as indicated by CSF neurofilament light chain levels [129]. This evidence concerns the gene APOA1 and myeloid sarcoma.